Drug company merger should benefit research

被引：0

|

作者：

Labreque, G

机构：

来源：

BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7130期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：494 / 494

页数：1

相关论文

共 50 条

[1] Yet another drug company merger proposed
不详
GASTROENTEROLOGY, 1999, 116 (02) : 236 - 236
[2] NOVA-TransCanada merger should benefit producers, consumers
不详
OIL & GAS JOURNAL, 1998, 96 (06) : 42 - 42
[3] Company merger
不详
NUCLEAR PLANT JOURNAL, 2001, 19 (01) : 13 - 13
[4] SHOULD THE NEXT DRUG BUST BE IN YOUR COMPANY
LYLES, RI
PERSONNEL JOURNAL, 1984, 63 (10) : 46 - 49
[5] How Much Should a Company Spend on Research?
Turner, Howard S.
HARVARD BUSINESS REVIEW, 1954, 32 (03) : 101 - 112
[6] Drug company payments - Speakers should declare funding
Taylor, Mark Stuart
BRITISH MEDICAL JOURNAL, 2008, 336 (7638): : 234 - 234
[7] DRUG COMPANY INFLUENCE Privatisation should not be NHS policy
Mann, Nick
BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
[8] SHOULD A DRUG COMPANY EMPLOYEE EDIT A MEDICAL JOURNAL
BEARN, AG
LANCET, 1986, 1 (8487): : 974 - 974
[9] SHOULD A DRUG COMPANY EMPLOYEE EDIT A MEDICAL JOURNAL
STAVEM, P
LANCET, 1986, 1 (8482): : 684 - 684
[10] SHOULD A DRUG COMPANY EMPLOYEE EDIT A MEDICAL JOURNAL
BURLEY, DM
LANCET, 1986, 1 (8484): : 801 - 801

← 1 2 3 4 5 →